{"frames":[],"tokens":["Acta","neuropathologica","."]}
{"frames":[{"target":{"name":"Cognitive_connection","spans":[{"start":2,"end":3,"text":"associated"}]},"annotationSets":[{"rank":0,"score":30.849396834804253,"frameElements":[{"name":"Concept_1","spans":[{"start":1,"end":2,"text":"biomarkers"}]},{"name":"Concept_2","spans":[{"start":3,"end":11,"text":"with disease heterogeneity in early Parkinson 's disease"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":4,"end":5,"text":"disease"}]},"annotationSets":[{"rank":0,"score":33.88193142037607,"frameElements":[]}]},{"target":{"name":"Weapon","spans":[{"start":5,"end":6,"text":"heterogeneity"}]},"annotationSets":[{"rank":0,"score":47.91251658070252,"frameElements":[{"name":"Weapon","spans":[{"start":5,"end":6,"text":"heterogeneity"}]}]}]},{"target":{"name":"Temporal_collocation","spans":[{"start":7,"end":8,"text":"early"}]},"annotationSets":[{"rank":0,"score":30.19833461184307,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":10,"end":11,"text":"disease"}]},"annotationSets":[{"rank":0,"score":36.09456946587963,"frameElements":[]}]},{"target":{"name":"Scrutiny","spans":[{"start":18,"end":19,"text":"study"}]},"annotationSets":[{"rank":0,"score":51.910723317578594,"frameElements":[]}]}],"tokens":["CSF","biomarkers","associated","with","disease","heterogeneity","in","early","Parkinson","'s","disease",":","the","Parkinson","'s","Progression","Markers","Initiative","study","."]}
{"frames":[{"target":{"name":"Event","spans":[{"start":1,"end":2,"text":"development"}]},"annotationSets":[{"rank":0,"score":35.090308544622346,"frameElements":[{"name":"Event","spans":[{"start":0,"end":23,"text":"The development of biomarkers to predict the progression of Parkinson 's disease -LRB- PD -RRB- from its earliest stage through its heterogeneous course"}]}]}]},{"target":{"name":"Expectation","spans":[{"start":5,"end":6,"text":"predict"}]},"annotationSets":[{"rank":0,"score":22.69854694783687,"frameElements":[{"name":"Phenomenon","spans":[{"start":6,"end":8,"text":"the progression"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":11,"end":12,"text":"disease"}]},"annotationSets":[{"rank":0,"score":42.39519152480569,"frameElements":[]}]},{"target":{"name":"Temporal_collocation","spans":[{"start":17,"end":18,"text":"earliest"}]},"annotationSets":[{"rank":0,"score":23.93113652747835,"frameElements":[{"name":"Trajector_period","spans":[{"start":18,"end":19,"text":"stage"}]}]}]},{"target":{"name":"Natural_features","spans":[{"start":21,"end":22,"text":"heterogeneous"}]},"annotationSets":[{"rank":0,"score":33.408749443890365,"frameElements":[{"name":"Locale","spans":[{"start":22,"end":23,"text":"course"}]}]}]},{"target":{"name":"Roadways","spans":[{"start":22,"end":23,"text":"course"}]},"annotationSets":[{"rank":0,"score":68.94145805037547,"frameElements":[{"name":"Roadway","spans":[{"start":22,"end":23,"text":"course"}]}]}]},{"target":{"name":"Judgment_communication","spans":[{"start":24,"end":25,"text":"critical"}]},"annotationSets":[{"rank":0,"score":84.02332886042574,"frameElements":[{"name":"Evaluee","spans":[{"start":0,"end":23,"text":"The development of biomarkers to predict the progression of Parkinson 's disease -LRB- PD -RRB- from its earliest stage through its heterogeneous course"}]}]}]},{"target":{"name":"Research","spans":[{"start":26,"end":27,"text":"research"}]},"annotationSets":[{"rank":0,"score":57.394244863730876,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":28,"end":29,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Event","spans":[{"start":29,"end":30,"text":"development"}]},"annotationSets":[{"rank":0,"score":35.31501628926365,"frameElements":[{"name":"Event","spans":[{"start":28,"end":29,"text":"therapeutic"}]}]}]}],"tokens":["The","development","of","biomarkers","to","predict","the","progression","of","Parkinson","'s","disease","-LRB-","PD","-RRB-","from","its","earliest","stage","through","its","heterogeneous","course","is","critical","for","research","and","therapeutic","development","."]}
{"frames":[{"target":{"name":"Scrutiny","spans":[{"start":9,"end":10,"text":"study"}]},"annotationSets":[{"rank":0,"score":52.7871577033533,"frameElements":[]}]},{"target":{"name":"Process_continue","spans":[{"start":12,"end":13,"text":"ongoing"}]},"annotationSets":[{"rank":0,"score":39.08199658505361,"frameElements":[{"name":"Event","spans":[{"start":0,"end":10,"text":"The Parkinson 's Progression Markers Initiative -LRB- PPMI -RRB- study"}]}]}]},{"target":{"name":"Political_locales","spans":[{"start":13,"end":14,"text":"international"}]},"annotationSets":[{"rank":0,"score":35.69607636653894,"frameElements":[{"name":"Locale","spans":[{"start":13,"end":14,"text":"international"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":17,"end":18,"text":"study"}]},"annotationSets":[{"rank":0,"score":44.495040757609665,"frameElements":[{"name":"Ground","spans":[{"start":18,"end":27,"text":"to validate biomarkers in drug-na < ve PD patients"}]}]}]},{"target":{"name":"Evaluative_comparison","spans":[{"start":28,"end":29,"text":"matched"}]},"annotationSets":[{"rank":0,"score":25.88136651450715,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":29,"end":30,"text":"healthy"}]},"annotationSets":[{"rank":0,"score":32.345605360601716,"frameElements":[]}]},{"target":{"name":"Control","spans":[{"start":30,"end":31,"text":"controls"}]},"annotationSets":[{"rank":0,"score":18.276272921157187,"frameElements":[{"name":"Dependent_entity","spans":[{"start":29,"end":30,"text":"healthy"}]}]}]}],"tokens":["The","Parkinson","'s","Progression","Markers","Initiative","-LRB-","PPMI","-RRB-","study","is","an","ongoing","international","multicenter",",","prospective","study","to","validate","biomarkers","in","drug-na","<","ve","PD","patients","and","matched","healthy","controls","-LRB-","HC","-RRB-","."]}
{"frames":[{"target":{"name":"Completeness","spans":[{"start":21,"end":22,"text":"total"}]},"annotationSets":[{"rank":0,"score":15.308703050612095,"frameElements":[{"name":"Whole","spans":[{"start":22,"end":23,"text":"tau"}]}]}]},{"target":{"name":"People_by_jurisdiction","spans":[{"start":38,"end":39,"text":"subjects"}]},"annotationSets":[{"rank":0,"score":16.660140392445136,"frameElements":[{"name":"Person","spans":[{"start":38,"end":39,"text":"subjects"}]}]}]},{"target":{"name":"Intentionally_act","spans":[{"start":47,"end":48,"text":"measures"}]},"annotationSets":[{"rank":0,"score":70.93727884409938,"frameElements":[]}]},{"target":{"name":"People_by_jurisdiction","spans":[{"start":54,"end":55,"text":"subjects"}]},"annotationSets":[{"rank":0,"score":19.25675544392335,"frameElements":[{"name":"Person","spans":[{"start":54,"end":55,"text":"subjects"}]}]}]}],"tokens":["We","quantified","cerebrospinal","fluid","-LRB-","CSF","-RRB-","alpha-synuclein","-LRB-","alpha-syn","-RRB-",",","amyloid-beta1-42","-LRB-","A","beta","-LRB-","1-42","-RRB-","-RRB-",",","total","tau","-LRB-","t-tau","-RRB-",",","and","tau","phosphorylated","at","Thr181","-LRB-","p-tau","-RRB-","in","660","PPMI","subjects","at","baseline",",","and","correlated","these","data","with","measures","of","the","clinical","features","of","these","subjects","."]}
{"frames":[{"target":{"name":"Locating","spans":[{"start":1,"end":2,"text":"found"}]},"annotationSets":[{"rank":0,"score":12.218788804241433,"frameElements":[{"name":"Perceiver","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Rank","spans":[{"start":9,"end":10,"text":"levels"}]},"annotationSets":[{"rank":0,"score":4.862725365134759,"frameElements":[{"name":"Rank","spans":[{"start":8,"end":9,"text":"p-tau"}]}]}]},{"target":{"name":"Evaluative_comparison","spans":[{"start":24,"end":25,"text":"compared"}]},"annotationSets":[{"rank":0,"score":23.723937338878812,"frameElements":[{"name":"Profiled_attribute","spans":[{"start":22,"end":24,"text":"in PD"}]}]}]},{"target":{"name":"Usefulness","spans":[{"start":31,"end":32,"text":"value"}]},"annotationSets":[{"rank":0,"score":17.627772451540224,"frameElements":[{"name":"Entity","spans":[{"start":32,"end":37,"text":"of the individual CSF biomarkers"}]}]}]},{"target":{"name":"People","spans":[{"start":34,"end":35,"text":"individual"}]},"annotationSets":[{"rank":0,"score":28.182690179295903,"frameElements":[{"name":"Person","spans":[{"start":34,"end":35,"text":"individual"}]}]}]},{"target":{"name":"Dimension","spans":[{"start":44,"end":45,"text":"large"}]},"annotationSets":[{"rank":0,"score":23.089013565276694,"frameElements":[{"name":"Object","spans":[{"start":45,"end":46,"text":"overlap"}]},{"name":"Dimension","spans":[{"start":44,"end":45,"text":"large"}]}]}]}],"tokens":["We","found","that","CSF","alpha-syn",",","t-tau","and","p-tau","levels",",","but","not","A","beta","-LRB-","1-42","-RRB-",",","were","significantly","lower","in","PD","compared","with","HC",",","while","the","diagnostic","value","of","the","individual","CSF","biomarkers","for","PD","diagnosis","was","limited","due","to","large","overlap","."]}
{"frames":[{"target":{"name":"Rank","spans":[{"start":1,"end":2,"text":"level"}]},"annotationSets":[{"rank":0,"score":3.8403396477696345,"frameElements":[]}]},{"target":{"name":"Increment","spans":[{"start":7,"end":8,"text":"other"}]},"annotationSets":[{"rank":0,"score":18.24669381085297,"frameElements":[{"name":"Class","spans":[{"start":8,"end":9,"text":"biomarkers"}]}]}]},{"target":{"name":"Evaluative_comparison","spans":[{"start":19,"end":20,"text":"compared"}]},"annotationSets":[{"rank":0,"score":24.104208799323494,"frameElements":[{"name":"Standard_item","spans":[{"start":20,"end":23,"text":"with tremor-dominant phenotype"}]},{"name":"Profiled_attribute","spans":[{"start":14,"end":19,"text":"PD patients with non-tremor-dominant phenotype"}]}]}]}],"tokens":["The","level","of","alpha-syn",",","but","not","other","biomarkers",",","was","significantly","lower","in","PD","patients","with","non-tremor-dominant","phenotype","compared","with","tremor-dominant","phenotype","."]}
{"frames":[{"target":{"name":"Communication_response","spans":[{"start":1,"end":2,"text":"addition"}]},"annotationSets":[{"rank":0,"score":42.40329916275448,"frameElements":[]}]},{"target":{"name":"Position_on_a_scale","spans":[{"start":7,"end":8,"text":"lowest"}]},"annotationSets":[{"rank":0,"score":18.815424829587354,"frameElements":[{"name":"Item","spans":[{"start":9,"end":10,"text":"beta"}]},{"name":"Value","spans":[{"start":7,"end":8,"text":"lowest"}]}]}]},{"target":{"name":"Cognitive_connection","spans":[{"start":28,"end":29,"text":"associated"}]},"annotationSets":[{"rank":0,"score":26.781093914811777,"frameElements":[{"name":"Concept_1","spans":[{"start":15,"end":18,"text":"highest t-tau/A beta"}]}]}]},{"target":{"name":"Increment","spans":[{"start":30,"end":31,"text":"more"}]},"annotationSets":[{"rank":0,"score":14.304241489041281,"frameElements":[{"name":"Class","spans":[{"start":31,"end":32,"text":"severe"}]}]}]},{"target":{"name":"Evaluative_comparison","spans":[{"start":34,"end":35,"text":"compared"}]},"annotationSets":[{"rank":0,"score":24.67702640965065,"frameElements":[{"name":"Standard_item","spans":[{"start":35,"end":43,"text":"with the highest or lowest quintiles , respectively"}]},{"name":"Profiled_attribute","spans":[{"start":33,"end":34,"text":"dysfunction"}]}]}]},{"target":{"name":"Position_on_a_scale","spans":[{"start":39,"end":40,"text":"lowest"}]},"annotationSets":[{"rank":0,"score":19.678441836356434,"frameElements":[{"name":"Value","spans":[{"start":39,"end":40,"text":"lowest"}]}]}]}],"tokens":["In","addition",",","in","PD","patients","the","lowest","A","beta","-LRB-","1-42","-RRB-",",","or","highest","t-tau/A","beta","-LRB-","1-42","-RRB-","and","t-tau/alpha-syn","quintile","in","PD","patients","were","associated","with","more","severe","non-motor","dysfunction","compared","with","the","highest","or","lowest","quintiles",",","respectively","."]}
{"frames":[{"target":{"name":"Vehicle","spans":[{"start":4,"end":5,"text":"model"}]},"annotationSets":[{"rank":0,"score":22.241789295894954,"frameElements":[{"name":"Vehicle","spans":[{"start":4,"end":5,"text":"model"}]}]}]},{"target":{"name":"Cognitive_connection","spans":[{"start":10,"end":11,"text":"associated"}]},"annotationSets":[{"rank":0,"score":28.76105942418999,"frameElements":[{"name":"Concept_1","spans":[{"start":7,"end":8,"text":"alpha-syn"}]},{"name":"Concept_2","spans":[{"start":11,"end":16,"text":"with worse cognitive test performance"}]}]}]},{"target":{"name":"Desirability","spans":[{"start":12,"end":13,"text":"worse"}]},"annotationSets":[{"rank":0,"score":27.144825705194506,"frameElements":[{"name":"Evaluee","spans":[{"start":15,"end":16,"text":"performance"}]},{"name":"Degree","spans":[{"start":12,"end":13,"text":"worse"}]}]}]},{"target":{"name":"Operational_testing","spans":[{"start":14,"end":15,"text":"test"}]},"annotationSets":[{"rank":0,"score":65.45618469267271,"frameElements":[]}]},{"target":{"name":"Performing_arts","spans":[{"start":15,"end":16,"text":"performance"}]},"annotationSets":[{"rank":0,"score":4.633366914677499,"frameElements":[{"name":"Type","spans":[{"start":14,"end":15,"text":"test"}]}]}]}],"tokens":["In","a","multivariate","regression","model",",","lower","alpha-syn","was","significantly","associated","with","worse","cognitive","test","performance","."]}
{"frames":[{"target":{"name":"Cardinal_numbers","spans":[{"start":2,"end":3,"text":"4"}]},"annotationSets":[{"rank":0,"score":30.09567359168868,"frameElements":[{"name":"Number","spans":[{"start":2,"end":3,"text":"4"}]},{"name":"Entity","spans":[{"start":3,"end":4,"text":"genotype"}]}]}]},{"target":{"name":"Membership","spans":[{"start":5,"end":6,"text":"associated"}]},"annotationSets":[{"rank":0,"score":7.853287178087229,"frameElements":[{"name":"Member","spans":[{"start":3,"end":4,"text":"genotype"}]},{"name":"Group","spans":[{"start":9,"end":12,"text":"of A beta"}]}]}]},{"target":{"name":"Rank","spans":[{"start":8,"end":9,"text":"levels"}]},"annotationSets":[{"rank":0,"score":7.479571061423627,"frameElements":[{"name":"Item","spans":[{"start":9,"end":12,"text":"of A beta"}]},{"name":"Rank","spans":[{"start":8,"end":9,"text":"levels"}]}]}]}],"tokens":["APOE","epsilon","4","genotype","was","associated","with","lower","levels","of","A","beta","-LRB-","1-42","-RRB-",",","but","neither","with","PD","diagnosis","nor","cognition","."]}
{"frames":[{"target":{"name":"Statement","spans":[{"start":2,"end":3,"text":"suggest"}]},"annotationSets":[{"rank":0,"score":120.97647695313411,"frameElements":[{"name":"Message","spans":[{"start":3,"end":21,"text":"that the measurement of CSF biomarkers in early-stage PD patients may relate to disease heterogeneity seen in PD"}]}]}]},{"target":{"name":"Likelihood","spans":[{"start":13,"end":14,"text":"may"}]},"annotationSets":[{"rank":0,"score":32.01775755686952,"frameElements":[{"name":"Hypothetical_event","spans":[{"start":4,"end":13,"text":"the measurement of CSF biomarkers in early-stage PD patients"}]}]}]},{"target":{"name":"Statement","spans":[{"start":14,"end":15,"text":"relate"}]},"annotationSets":[{"rank":0,"score":98.32167270450164,"frameElements":[{"name":"Message","spans":[{"start":15,"end":21,"text":"to disease heterogeneity seen in PD"}]},{"name":"Speaker","spans":[{"start":4,"end":13,"text":"the measurement of CSF biomarkers in early-stage PD patients"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":16,"end":17,"text":"disease"}]},"annotationSets":[{"rank":0,"score":33.88193142037607,"frameElements":[]}]},{"target":{"name":"Leadership","spans":[{"start":17,"end":18,"text":"heterogeneity"}]},"annotationSets":[{"rank":0,"score":61.81122789710613,"frameElements":[{"name":"Leader","spans":[{"start":17,"end":18,"text":"heterogeneity"}]}]}]},{"target":{"name":"Perception_experience","spans":[{"start":18,"end":19,"text":"seen"}]},"annotationSets":[{"rank":0,"score":73.60857449577412,"frameElements":[{"name":"State","spans":[{"start":19,"end":21,"text":"in PD"}]},{"name":"Phenomenon","spans":[{"start":16,"end":18,"text":"disease heterogeneity"}]}]}]}],"tokens":["Our","data","suggest","that","the","measurement","of","CSF","biomarkers","in","early-stage","PD","patients","may","relate","to","disease","heterogeneity","seen","in","PD","."]}
{"frames":[{"target":{"name":"Perception_active","spans":[{"start":1,"end":2,"text":"observations"}]},"annotationSets":[{"rank":0,"score":66.01269899022624,"frameElements":[]}]},{"target":{"name":"People_by_jurisdiction","spans":[{"start":4,"end":5,"text":"subjects"}]},"annotationSets":[{"rank":0,"score":17.70146689457104,"frameElements":[{"name":"Person","spans":[{"start":4,"end":5,"text":"subjects"}]}]}]},{"target":{"name":"Required_event","spans":[{"start":6,"end":7,"text":"needed"}]},"annotationSets":[{"rank":0,"score":29.452600444418035,"frameElements":[{"name":"Required_situation","spans":[{"start":0,"end":5,"text":"Longitudinal observations in PPMI subjects"}]}]}]},{"target":{"name":"Communicate_categorization","spans":[{"start":8,"end":9,"text":"define"}]},"annotationSets":[{"rank":0,"score":36.7770928506365,"frameElements":[{"name":"Item","spans":[{"start":9,"end":12,"text":"their prognostic performance"}]}]}]},{"target":{"name":"Performing_arts","spans":[{"start":11,"end":12,"text":"performance"}]},"annotationSets":[{"rank":0,"score":5.142451016474599,"frameElements":[{"name":"Type","spans":[{"start":10,"end":11,"text":"prognostic"}]},{"name":"Performance","spans":[{"start":11,"end":12,"text":"performance"}]}]}]}],"tokens":["Longitudinal","observations","in","PPMI","subjects","are","needed","to","define","their","prognostic","performance","."]}
